Based on the Kalbe Farma Tbk PT ADR stock forecast from 0 analysts, the average analyst target price for Kalbe Farma Tbk PT ADR is not available over the next 12 months. Kalbe Farma Tbk PT ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Kalbe Farma Tbk PT ADR is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Kalbe Farma Tbk PT ADR’s stock price was USD 21.11. Kalbe Farma Tbk PT ADR’s stock price has changed by +0.00% over the past week, -6.56% over the past month and -27.46% over the last year.
No recent analyst target price found for Kalbe Farma Tbk PT ADR
No recent average analyst rating found for Kalbe Farma Tbk PT ADR
Company Overview Kalbe Farma Tbk PT ADR
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Kalbe Farma Tbk PT ADR (PTKFY)
Loading...
Unadjusted Closing Price for Kalbe Farma Tbk PT ADR (PTKFY)
Loading...
Share Trading Volume for Kalbe Farma Tbk PT ADR Shares
Loading...
Compare Performance of Kalbe Farma Tbk PT ADR Shares
Stock Target Advisor's fundamental analysis for Kalbe Farma Tbk PT ADR's stock is Very Bearish.
Unfortunately we do not have enough data on PTKFY's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on PTKFY's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on PTKFY's stock to indicate if its overvalued.
The last closing price of PTKFY's stock was USD 21.11.
Unfortunately we do not currently have any market capitalization data for PTKFY's stock.
Unfortunately we do not have enough analyst data on PTKFY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Kalbe Farma Tbk PT ADR's stock.
Sorry, we do not have any data on the number of employees for Kalbe Farma Tbk PT ADR.
Sorry we do not have any infomation available on Kalbe Farma Tbk PT ADR's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
